THE POTENTIAL CLINICAL-SIGNIFICANCE OF THE ISONIAZID ACETYLATOR PHENOTYPE IN THE TREATMENT OF PULMONARY TUBERCULOSIS

被引：48

作者：

ELLARD, GA

机构：

来源：

TUBERCLE | 1984年 / 65卷 / 03期

关键词：

D O I：

10.1016/0041-3879(84)90079-5

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：211 / 227

页数：17

共 98 条

[51] JENNEY EH, 1958, J PHARMACOL EXP THER, V122, P110
[52] JOHNSON JD, 1980, J LAB CLIN MED, V95, P429
[53] KAILASAM S, 1975, INDIAN J MED RES, V63, P323
[54] KENT P W, 1970, Tubercle, V51, P24, DOI 10.1016/0041-3879(70)90125-X
[55] KRISHNAMURTHY DV, 1967, B WORLD HEALTH ORGAN, V36, P853
[56] LADERO JM, 1982, ANN CLIN RES, V14, P187
[57] LADERO JM, 1979, GASTROENTEROLOGIA HE, V2, P236
[58] LADU BN, 1972, FED PROC, V31, P1276
[59] LARSSON R, 1977, ACTA MED SCAND, V201, P223
[60] DETERMINATION OF ISONIAZID AND ITS HYDRAZINO METABOLITES, ACETYLISONIAZID, ACETYLHYDRAZINE, AND DIACETYLHYDRAZINE IN HUMAN-PLASMA BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY
LAUTERBURG, BH
SMITH, CV
MITCHELL, JR
[J]. JOURNAL OF CHROMATOGRAPHY, 1981, 224 (03): : 431 - 438